Skip to content

Haemonetics Corp

company based in Braintree, Massachusetts, USA

HAE NYSE SEC CIK 313143

Follow Haemonetics Weekly email: filings, results, news

News

12 stories filed under Haemonetics, grouped into ongoing threads

Haemonetics q1

Thread · 3 stories

Haemonetics Q1 Earnings Call Highlights

Earnings 47 d ago

Haemonetics Corporation 2027 Q1 - Results - Earnings Call Presentation

Earnings 49 d ago 2 sources

Haemonetics Q1 FY2027 slides: revenue beats, margins compress

Earnings 49 d ago

More coverage

Citizens raises Pharvaris stock price target to $79 on HAE therapy

Markets 15 d ago

TD Cowen initiates BioCryst stock with buy rating on HAE drug outlook

Markets 16 d ago also on TD

Citizens reiterates Intellia stock rating on HAE opportunity potential

Markets 16 d ago

BioCryst Pharmaceuticals: Owning Both Sides Of The HAE Preference Curve

Markets 27 d ago also on BCRX

Haemonetics: Worth Speculating On This Recurring Medtech Plasma Model

Markets 34 d ago

Haemonetics announces non-exclusive supply agreement with CSL Plasma

Markets 37 d ago 2 sources also on CSL

Why is Haemonetics stock surging today?

Markets 37 d ago

Haemonetics earnings beat by $0.05, revenue topped estimates

Earnings 49 d ago

Haemonetics earnings up next as estimates cool ahead of print

Earnings 50 d ago

Next results

NOV5

FY 2026 results

Thursday · estimated from the filing cadence

Profile

Headquarters: BOSTON, MA, United States
Founded: 1971
Employees: 3,300
Sector: Healthcare
Industry: Surgical & Medical Instruments & Apparatus
Website: haemonetics.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

Next results · estimated from the filing cadence (SEC EDGAR)

News · 12 stories clustered from the RSS aggregator